Christina Maria Zelano

Title: Christina Maria Zelano: Inventor in Breath-Based Diagnostics.

Introduction

Christina Maria Zelano is an inventor associated with Chicago, Illinois. Her patent work includes methods that analyze exhaled breath to detect respiratory pathogens and assess biomarkers relevant to neurological disease. She is associated with Northwestern University and the Rehabilitation Institute of Chicago.

Latest Patents

Zelano is named on two patents. One describes determining whether a person has SARS-CoV-2 or another respiratory pathogen by collecting and testing condensed exhaled breath. The method is intended to help assess whether someone may transmit the pathogen to others.

Another patent, “Biomarkers in Nasal Exhaled Breath,” describes collecting a nasal breath sample and measuring its tau protein concentration. The disclosed approach uses that measurement to help diagnose or assess a person’s risk of tauopathy.

Career Highlights

Zelano’s patent portfolio connects breath-sample analysis with potential applications in infectious-disease detection and neurological assessment. Her work is associated with Northwestern University and the Rehabilitation Institute of Chicago. The supplied information identifies her as an inventor on 2 patents.

Collaborations

Gregory Lane and Jordan Grafman are identified as Zelano’s coworkers. The provided information does not specify their roles in the patents or the nature of their collaborations.

Conclusion

Christina Maria Zelano’s inventions explore how exhaled-breath samples may support pathogen detection and tauopathy assessment, reflecting a focus on diagnostic methods with potential clinical applications.